News
Hosted on MSN10d
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung diseaseAn experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
10don MSN
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
A three-drug combination worked better than any of them alone in treating ALS caused by mutations in the SOD1 gene, per a new ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
News Medical on MSN6d
Study Suggests Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung DiseaseIn a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback